Chromadex Corp Stock Beneish M Score

CDXC Stock  USD 7.44  0.19  2.49%   
This module uses fundamental data of Chromadex Corp to approximate the value of its Beneish M Score. Chromadex Corp M Score tells investors if the company management is likely to be manipulating earnings. The score is calculated using eight financial indicators that are adjusted by a specific multiplier. Please note, the M Score is a probabilistic model and cannot detect companies that manipulate their earnings with 100% accuracy. Check out Chromadex Corp Piotroski F Score and Chromadex Corp Altman Z Score analysis.
For information on how to trade Chromadex Stock refer to our How to Trade Chromadex Stock guide.
  
At present, Chromadex Corp's Net Debt To EBITDA is projected to slightly grow based on the last few years of reporting. The current year's Interest Debt Per Share is expected to grow to 0.02, whereas Short and Long Term Debt Total is forecasted to decline to about 1.7 M. At present, Chromadex Corp's Operating Cash Flow Per Share is projected to increase slightly based on the last few years of reporting. The current year's Average Payables is expected to grow to about 6.3 M, whereas Price To Sales Ratio is forecasted to decline to 1.22.
At this time, it appears that Chromadex Corp is a possible manipulator. The earnings manipulation may begin if Chromadex Corp's top management creates an artificial sense of financial success, forcing the stock price to be traded at a high price-earnings multiple than it should be. In general, excessive earnings management by Chromadex Corp executives may lead to removing some of the operating profits from subsequent periods to inflate earnings in the following periods. This way, the manipulation of Chromadex Corp's earnings can lead to misrepresentations of actual financial condition, taking the otherwise loyal stakeholders on to the path of questionable ethical practices and plain fraud.
10.29
Beneish M Score - Possible Manipulator
Elasticity of Receivables

0.59

Focus
Asset Quality

38.74

Focus
Expense Coverage

0.63

Focus
Gross Margin Strengs

0.58

Focus
Accruals Factor

0.63

Focus
Depreciation Resistance

1.87

Focus
Net Sales Growth

1.05

Focus
Financial Leverage Condition

0.62

Focus

Chromadex Corp Beneish M-Score Indicator Trends

The cure to earnings manipulation is the transparency of financial reporting. It will typically remove the temptation of the top executives to inflate earnings (i.e., to promote the idea of 'winning at any cost'). Because a healthy internal audit department can enhance transparency, the board should promote the auditors' access to all the record-keeping systems across the enterprise. For example, if Chromadex Corp's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back.
Current ValueLast YearChange From Last Year 10 Year Trend
Net Receivables3.2 M5.2 M
Way Down
Slightly volatile
Total Revenue87.7 M83.6 M
Sufficiently Up
Slightly volatile
Total Assets28.4 M55 M
Way Down
Slightly volatile
Total Current Assets52 M49.5 M
Sufficiently Up
Slightly volatile
Non Current Assets Total4.3 M5.4 M
Significantly Down
Slightly volatile
Depreciation And Amortization863.7 K1.7 M
Way Down
Slightly volatile
Selling General Administrative16.5 M25 M
Way Down
Slightly volatile
Total Current Liabilities21.7 M20.6 M
Sufficiently Up
Slightly volatile
Non Current Liabilities Total6.2 M5.9 M
Sufficiently Up
Slightly volatile
Short Term Debt1.5 M1.4 M
Sufficiently Up
Slightly volatile
Gross Profit Margin0.350.6076
Way Down
Slightly volatile

Chromadex Corp Beneish M-Score Driver Matrix

One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to detect the potential manipulation of earnings. Understanding the correlation between Chromadex Corp's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Chromadex Corp in a much-optimized way. Analyzing correlations between earnings drivers directly associated with dollar figures is the most effective way to find Chromadex Corp's degree of accounting gimmicks and manipulations.

About Chromadex Corp Beneish M Score

M-Score is one of many grading techniques for value stocks. It was developed by Professor M. Daniel Beneish of the Kelley School of Business at Indiana University and published in 1999 under the paper titled The Detection of Earnings Manipulation. The Beneish score is a multi-factor model that utilizes financial identifiers to compile eight variables used to classify whether a company has manipulated its reported earnings. The variables are built from the officially filed financial statements to create a final score call 'M Score.' The score helps to identify companies that are likely to manipulate their profits if they show deteriorating gross margins, operating expenses, and leverage against growing revenue.

Depreciation And Amortization

863,718

At present, Chromadex Corp's Depreciation And Amortization is projected to increase significantly based on the last few years of reporting.

Chromadex Corp Earnings Manipulation Drivers

Although earnings manipulation is typically not the result of intentional misconduct by the c-level executives, it is still a widespread practice by the senior management of public companies such as Chromadex Corp. It is usually done by a series of misrepresentations of various accounting rules and operating activities across multiple financial cycles. The best way to spot the manipulation is to examine the historical financial statement to find inconsistencies in earning reports to find trends in assets or liabilities that are not sustainable in the future.
201920202021202220232024 (projected)
Net Receivables2.2M2.7M5.2M8.5M5.2M3.2M
Total Revenue46.3M59.3M67.4M72.1M83.6M87.7M
Total Assets40.2M38.4M57.8M54.1M55.0M28.4M
Total Current Assets33.5M32.2M48.9M46.6M49.5M52.0M
Net Debt(17.1M)(14.9M)(23.3M)(16.0M)(23.9M)(22.7M)
Short Term Debt853K1.2M1.1M1.4M1.4M1.5M
Operating Income(31.3M)(19.9M)(27.1M)(18.6M)(5.6M)(5.9M)
Investments(49K)(165K)(409K)(334K)(294K)(279.3K)
Gross Profit Margin0.560.60.620.590.610.35

Chromadex Corp ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Chromadex Corp's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Chromadex Corp's managers, analysts, and investors.
Environmental
Governance
Social

About Chromadex Corp Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Chromadex Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chromadex Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chromadex Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Chromadex Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Chromadex Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Chromadex Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Chromadex Corp Stock:
Check out Chromadex Corp Piotroski F Score and Chromadex Corp Altman Z Score analysis.
For information on how to trade Chromadex Stock refer to our How to Trade Chromadex Stock guide.
You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chromadex Corp. If investors know Chromadex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chromadex Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
0.02
Revenue Per Share
1.215
Quarterly Revenue Growth
0.312
Return On Assets
0.0051
Return On Equity
0.0482
The market value of Chromadex Corp is measured differently than its book value, which is the value of Chromadex that is recorded on the company's balance sheet. Investors also form their own opinion of Chromadex Corp's value that differs from its market value or its book value, called intrinsic value, which is Chromadex Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chromadex Corp's market value can be influenced by many factors that don't directly affect Chromadex Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chromadex Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Chromadex Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chromadex Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.